AccessPak for HIV PEP Expanded with Kaletra and Halobetasol and Tazarotene
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Halobetasol and Tazarotene and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: halobetasol / tazarotene topical
Brand name: Duobrii
Synonyms: Halobetasol and tazarotene topical
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Halobetasol and tazarotene topical
- AccessPak for HIV PEP Expanded with Kaletra-Halobetasol Cream
- AccessPak for HIV PEP Expanded with Kaletra-Halobetasol Cream and Ointment
- AccessPak for HIV PEP Expanded with Kaletra-Halobetasol Cream and Ointment with Lactic Acid Cream
- AccessPak for HIV PEP Expanded with Kaletra-Halobetasol Foam
- AccessPak for HIV PEP Expanded with Kaletra-Halobetasol Lotion
- Halobetasol and Tazarotene-AccessPak for HIV PEP Expanded with Viracept
- Halobetasol and Tazarotene-Accolate
- Halobetasol and Tazarotene-Accretropin
- Halobetasol and Tazarotene-Accucaine
- Halobetasol and Tazarotene-AccuHist Drops
- Halobetasol and Tazarotene-AccuHist PDX Drops